🟢 Krystal Biotech is trading 4.1% up today amid a bullish biotech tape and risk-on sentiment

Krystal Biotech is trading at $348.82 (4.1% up), extending its recent upward trajectory following its addition to the S&P MidCap 400 and a strong performance throughout 2026.

• The move appears to be driven primarily by a bullish biotech tape and a broader risk-on market environment.
• No fresh company-specific catalysts, such as earnings reports, FDA decisions, or new analyst calls, have emerged today.